Owkin Expands Oncology Pipeline with AI and EP2/EP4 Dual Inhibitor from Idorsia
Owkin, a pioneering TechBio company leveraging advanced causal* AI for precision drug discovery, has announced a significant expansion of its …
#Drug Targets
Nabla Bio Advances Generative Protein Design with $26M Series A Funding
Nabla Bio, a biotechnology firm specializing in generative protein design, has successfully closed a $26 million Series A financing round, …
Cyclica's Chemical Probes for DCAF1
Cyclica is designing chemical probes for DCAF1, a potentially novel target for protein degradation, with proprietary technology MatchMaker DCAF1 was …
Covid-19 Vaccines in Development and Use (List Not Updated)
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is a …
Structural Basis of Poxvirus Transcription Revealed
In order for viruses to proliferate, they usually need to be supported by infected cells. In many cases, the molecules …
Hunting Dark Genes For Druggable Targets
About one in three human proteins is understudied. Even when quantifying data is available from multiple sources, "dark" genes and proteins …
"Hot" Research Areas in Drug Discovery - 2019
Things like gene editing, stem cells, immunotherapies and new types of biologics are now mega-trends in the pharmaceutical industry, widely …
Three Insights For Immuno-oncology Drug Discovery
Immunotherapies are hot property. Immuno-oncology is the crown jewel. But the road to riches, and more importantly cancer cures, is …
How Many Drug Targets Are There? A Status Update Review
The question is often raised, but the answer remains to be uncovered because the definition of drug "target" continues to …